Neofect Co.Ltd
Neofect Co., Ltd. researches, develops, manufactures, and sells rehabilitation medical devices and contents for stroke and spinal cord injuries. The company offers Neofect Smart Glove, a high-tech rehab device that measures movements of the forearm, wrist, and digits with accelerometer and bending sensors; Neofect Smart Kids for hand rehabilitation in children; Neofect Smart Board, a high-tech me… Read more
Neofect Co.Ltd - Asset Resilience Ratio
Neofect Co.Ltd (290660) has an Asset Resilience Ratio of 0.48% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2024)
This chart shows how Neofect Co.Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Neofect Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩333.62 Million | 0.48% |
| Total Liquid Assets | ₩333.62 Million | 0.48% |
Asset Resilience Insights
- Limited Liquidity: Neofect Co.Ltd maintains only 0.48% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Neofect Co.Ltd Industry Peers by Asset Resilience Ratio
Compare Neofect Co.Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
|
Osang Healthcare Co.,Ltd
KQ:036220 |
Medical Devices | 9.34% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
Annual Asset Resilience Ratio for Neofect Co.Ltd (2016–2024)
The table below shows the annual Asset Resilience Ratio data for Neofect Co.Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 37.35% | ₩27.03 Billion | ₩72.36 Billion | +4.46pp |
| 2023-12-31 | 32.89% | ₩23.59 Billion | ₩71.71 Billion | +29.84pp |
| 2022-12-31 | 3.05% | ₩1.54 Billion | ₩50.37 Billion | -8.00pp |
| 2021-12-31 | 11.05% | ₩5.80 Billion | ₩52.54 Billion | -13.75pp |
| 2020-12-31 | 24.80% | ₩14.36 Billion | ₩57.91 Billion | +5.47pp |
| 2019-12-31 | 19.33% | ₩9.09 Billion | ₩47.02 Billion | -42.92pp |
| 2018-12-31 | 62.25% | ₩22.36 Billion | ₩35.92 Billion | +23.74pp |
| 2017-12-31 | 38.51% | ₩3.93 Billion | ₩10.21 Billion | -19.32pp |
| 2016-12-31 | 57.83% | ₩4.59 Billion | ₩7.93 Billion | -- |